Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.
Forces NJ Medicaid inpatient psychiatric facilities to receive outpatient reimbursement rates for long-acting injectable antipsychotics, potentially reducing provider revenue while increasing medication access.